dimarts, 28 d’abril del 2015

Haemonetics ends its fiscal year in Q4 red

Haemonetics ends its 2015 fiscal year in the red, posting a loss for the 4th quarter on uncertainty in Russia, currency fluctuations and restructuring costs.

Haemonetics ends year in the red

Haemonetics (NYSE:HAE) finished out its 2015 fiscal 4th quarter in the red, hammered by a U.S. market shift that affected its blood center business, uncertainty in Russia, currency fluctuations and restructuring.

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EzKGPG

Cap comentari:

Publica un comentari a l'entrada